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The purification of malignant cells from many
human solid tumours has become a relatively un-
complicated procedure (Pretlow et al., 1973; Helms
et al., 1976; Brattain et al., 1977; Pretlow & Pret-
low, 1980, 1984; Hemstreet et al., 1980; Pretlow et
al., 1984). The purification of malignant cells from
the blood of patients with cancer is a much more
difficult objective (Engell, 1955; Roberts et al.,
1958). During the last quarter of a century, there
has been comparatively little work directed towards
this problem; but its solution should be facilitated
by the availability of modem, selective techniques
for the purification and culture of malignant cells.
We studied patients with metastatic melanoma,
since the identification of these malignant cells
growing in soft agar is facilitated by the
identification of melanin by light microscopy and
melanosomes and premelanosomes by electron
microscopy.
Blood was drawn into heparinized vacuum tubes
from the antecubital veins of 5 normal donors and
9 patient volunteers with metastatic melanoma who
had not had chemotherapy or radiation therapy for
at least 2 weeks prior to phlebotomy. Gradients for
isopycnic centrifugation consisted of 8ml cushions
of undiluted Percoll overlaid by 70ml, continuous,
linear gradients made with 35ml of 90% Percoll
adjusted to 300mosmoll-1 with sodium chloride
(Pertoft & Laurent, 1982) mixed with 35ml of
Joklik's modification of minimum essential medium
(Gibco, Grand Island, NY, USA) with a two-
chambered gradient generator (Lido Glass, Stirling,
NJ, USA) as described previously (Pretlow et al.,
1975). Both gradient solutions contained 5Uml-1
heparin and 5 ugml-1 gentamycin. They were con-
tained in polycarbonate centrifuge tubes (Tube No.
2806, International Equipment Co., Needham
Heights, Mass., USA). The 20ml samples layered
over the gradients consisted of 10ml of blood
diluted with an equal part of Joklik's modification
of minimum essential medium. Centrifugation was
carried out at 4°C for 30min at 1950g measured at
the sample-gradient interface.
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Four-ml fractions were collected as described
(Pretlow et al., 1975). The densities of the respective
fractions were determined from the refractive in-
dices measured with an Abbe 3L refractometer
together with information furnished by Pharmacia
Fine Chemicals (Piscataway, NJ, USA). Fractions
ranging in density from 1.050 to 1.088gml-l were
plated in soft agar. Greater than 95% of the cells in
each of these fractions were lymphocytes and
monocytes as identified by Haemacolor stain (E.M.
Industries, Inc., Gibbstown, NJ, USA). Any frac-
tion with less than a million cells was pooled with
the contiguous, denser fraction.
Just prior to addition of the agar to the cells, cell
counts were performed with haemocytometer cham-
bers, the ability of the cells to exclude trypan blue
was assessed, and the cells were passed through
Nitex (TETKO, Inc., Elmsford, NY, USA) with a
pore diameter of 48gm. Cells were plated in 1 ml of
medium that consisted of 0.3% agar, 83.2% modi-
fied McCoy's medium (Pike & Robinson, 1970),
and 16.5% foetal bovine serum. Cells from
each fraction were plated at 1.0, 0.5, and
0.33 x 106ml-1. The underlayer on which the cells
were plated consisted of 1 ml of 0.5% agar in the
same medium. Cultures were incubated at 37°C in
humidified 5% carbon dioxide in air. Cultures were
checked within 24h for cell clumping and were then
checked periodically for up to 4 weeks. Clumps
larger than 4 cells were not observed within the first
24h. Cultures were terminated by fixation with 3%
glutaraldehyde and were prepared for light and
electron microscopy (Zucker-Franklin & Grusky,
1974).
Cultures from 5 normal volunteers and 4 of 9
patients with metastatic melanoma exhibited no
growth. The cells shrank over a period of 5-10
days. After 3 weeks most of the cells dissolved or
appeared refractile and degenerated.
Cells from 5 of 9 samples from patients with
metastatic melanoma grew in soft agar. This
growth occurred despite the fact that cells purified
from all blood samples and inoculated into culture
contained <2% (usually <1%) of cells that could
not be identified clearly as blood cells, i.e., atypical
and/or malignant cells were rare. Initially, they
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formed clusters. Cells from 4 of the 5 patients
whose cells formed clusters grew to form colonies
with more than 30 cells (Figure 1). All clusters were
observed before the end of the first 11 days in
culture. Colonies appeared as early as the fifth day
of culture; no new colonies developed after 2 weeks
in culture. The cloning efficiencies for these cultures
ranged from 0.0065% to 0.0002% of nucleated cells
plated; however, the cloning efficiencies of the
malignant cells cannot be accurately estimated,
since the proportion of malignant cells in the
inoculum is unknown.
Multiple colonies in agar were examined by light
and electron microscopy with the method of
Figure 1 A typical colony from a patient with meta-
static melanoma. Cells were often more intensely pig-
mented in the centres of colonies than at the
peripheries.
Zucker-Franklin & Grusky (1974). Cells that con-
tained pigment were common by light microscopy.
From three patients, cells in colonies were found
that were identifiable as melanocytes (Figure 2) by
virtue of the ultrastructural identification of pre-
melanosomes and melanosomes in early stages of
melanization such as those described previously in
tumours (Seije et al., 1963; Kanzaki et al., 1977;
Costa et al., 1973). Sections of some colonies failed
to reveal premelanosomes and melanosomes. When
premelanosomes and melanosomes were observed,
they were not seen in all sections from the same
colony.
Systemic metastases are followed by death in
most patients, and haematogenous spread is viewed
by many as one of the important early steps in this
process (Fidler & Nicolson, 1976; Weiss & Ward,
1983). Numerous investigators (Engell, 1955;
Goldblatt & Nadel, 1965; Circulating Cancer Cell
Cooperative, 1962) have published warnings regard-
ing the uncertainties of morphological identification
of some such cells. Most investigators agree that
small numbers of malignant cells can be found in
the blood streams of many patients with metastatic
solid tumours; however, precise quantification is
complicated both by their low concentrations and
by the presence in the blood stream of similarly
infrequent, atypical and/or immature blood cells
and megakaryocytes.
Soft agar techniques were used for the growth of
transformed cells by MacPherson & Montagnier
(1964), permitted the growth of cells from the
tumours of children by McAllister & Reed (1968),
Figure 2 Ultrastructurally, cells in colonies contained many dark bodies such as those described in malignant
melanocytes. Some showed concentrically lamellar substructure and lattice formation. ( x 60,000) Right top
inset shows positive dopa reaction within dark body with concentrically lamellar structure. ( x 60,000) Middle
top inset shows melanosome with irregularly disposed lamellae such as described in malignant melanocytes.
( x 68,000) Left top inset shows elliptical dark body with vertical concentric lamellar structure and occasional
horizontal lattice formation. ( x 68,000)SHORT COMMUNICATION 413
and were adapted for the assay of antineoplastic
drug sensitivity by Hamburger & Salmon (1977);
Salmon et al. (1978). Because haematopoietic stem
cells have grown in other systems for the culture of
cells in soft agar (Chervenick & Boggs, 1971;
Kurnick & Robinson, 1971), we monitored cultures
from normal donors for the development of
colonies. The fact that no colonies developed from
the cells of normal donors and the fact that pre-
melanosomes and melanosomes were identified in
some of the colonies that grew from the cells of
patients with melanoma lead us to believe that the
present culture is selective for the growth of
neoplastic cells from blood and against the growth
of haematopoietic stem cells.
While the use of the system described here will
have many of the same problems in interpretation
of data as described for the clonogenic assay (Von
Hoff, 1983; Selby et al., 1983), the procurement of
malignant cells from peripheral blood may offer
some advantages over the dissociation of cells from
solid tumours. The problems of damage to cells
during enzymatic and/or mechanical disaggregation
of solid tumours will be avoided. Multiple sequen-
tial samples may be taken with relatively little
trauma during the course of the patient's disease. In
obtaining cells from peripheral blood, one may be
selecting for subpopulations of cells that are differ-
ent from those in the primary tumour in their
biological capacities.
There have been many reports (Schirrmacher &
Waller, 1982; Butler & Gullino, 1975; Glaves, 1983;
Mayhew & Glaves, 1984; Liotta et al., 1974;
Suzuki, 1984) of the isolation and/or quantification
of circulating malignant cells in laboratory animals
with experimental, usually transplanted tumours.
To our knowledge, this is the first report that
suggests that malignant cells can be purified from
the peripheral blood of a large proportion of
humans with any kind of solid tumour.
The limited (10ml) quantity of blood that we
used in our experiments permitted us to grow
malignant cells from the blood of 5 of 9 patients
with metastatic malignant melanoma; this observa-
tion suggests many other experiments that might
be accomplished with larger numbers of cells. Addi-
tional work with larger quantities of blood will be
required to characterize circulating malignant mela-
noma cells, i.e. to investigate their true cloning
efficiency, to determine if subpopulations of mal-
ignant cells with different cloning efficiencies or
other differences might be identified in different
fractions of density gradients. Immunological
probes would facilitate one approach to determin-
ing the proportion of cells plated that are actually
melanoma cells; this information would be required
before one could inquire about the 'real' cloning
efficiency of circulating, malignant melanocytes.
Since none of the blood donors had tumours on
their extremities distal to the anticubital fossa, it is
likely that the malignant cells in our samples of
blood were highly selected and representative only
of cells that survived filtration by both the pulmon-
ary and distal capillary beds. It would be interest-
ing to compare these cells with those derived from
(a) veins that drain tumours, (b) disaggregation of
solid tumours, and (c) disaggregation of metastases.
The varied consequences of different methods for
obtaining malignant cells in suspension from solid
tumours have been discussed previously (Pretlow &
Pretlow, 1984).
The immediate problem with the use of peri-
pheral blood for the tumour stem cell assay is the
collection of sufficient numbers of cells. To date,
we have used only 10ml samples, only isopycnic
centrifugation and culture in soft agar as selective
methods, and only cells from patients with meta-
static melanoma. One would anticipate that larger
volumes of blood and additional methods for the
purification of malignant cells reviewed by us pre-
viously (Pretlow & Pretlow, 1982, 1983) would
enhance one's ability to obtain larger numbers of
colonies.
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